Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
CN Stock MarketDetailed Quotes
Suzhou Fushilai Pharmaceutical (301258)
- 35.03
- +0.85+2.49%
Market Closed Jan 15 15:00 CST
3.21BMarket Cap42.26P/E (TTM)
35.48High33.97Low19.49KlotVolume34.16Open34.18Prev Close68.05MTurnover2.19%Turnover Ratio195.70P/E (Static)91.67MShares39.2852wk High1.68P/B3.12BFloat Cap20.4752wk Low41.02Limit Up89.07MShs Float78.72Historical High27.34Limit Down4.42%Range %18.97Historical Low0.09Dividend TTM34.91Avg Price6.94KlotAsk0.26%Div Yield TTM100Lot Size11.82KlotBid
Suzhou Fushilai Pharmaceutical (301258) Income Statement
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 3.23%322.58M | 3.36%223.91M | 17.44%113.08M | -12.23%429.47M | -19.59%312.49M | -27.14%216.64M | -38.47%96.29M | -13.89%489.29M | -2.35%388.63M | 9.17%297.35M |
| Operating revenue | 3.23%322.58M | 3.36%223.91M | 17.44%113.08M | -12.23%429.47M | -19.59%312.49M | -27.14%216.64M | -38.47%96.29M | -13.89%489.29M | -2.35%388.63M | 9.17%297.35M |
| Other operating revenue | ---- | 104.76%2.9M | ---- | -44.10%3.46M | ---- | -71.11%1.41M | ---- | -67.86%6.19M | ---- | -63.02%4.89M |
| Total operating cost | 2.70%322.27M | 4.67%220.3M | 18.80%110.68M | 9.51%426.1M | 8.71%313.8M | 4.10%210.46M | -11.56%93.17M | 5.89%389.09M | 12.02%288.66M | 14.84%202.17M |
| Operating cost | 7.03%265.91M | 8.75%183.16M | 25.52%92.8M | 14.53%345.17M | 10.65%248.44M | 4.28%168.43M | -11.93%73.94M | -3.15%301.38M | 0.84%224.54M | 8.46%161.52M |
| Operating tax surcharges | 21.98%3.55M | 9.91%2.35M | 31.93%1.23M | -25.85%4.01M | -36.14%2.91M | -36.66%2.14M | -44.37%933.72K | 6.13%5.41M | 24.12%4.55M | 17.38%3.38M |
| Operating expense | -22.64%2.96M | -32.35%1.86M | -40.25%639.31K | 7.53%5.26M | 3.72%3.83M | 18.99%2.75M | -6.86%1.07M | 10.10%4.89M | 9.98%3.69M | 12.27%2.31M |
| Administration expense | -13.08%26.73M | -14.15%17.69M | -3.71%8.49M | -10.16%41.32M | -7.61%30.76M | -9.06%20.61M | -12.19%8.82M | 6.46%46M | 5.37%33.29M | 5.31%22.66M |
| Financial expense | 21.15%-3.58M | 61.35%-2.49M | 51.52%-1.41M | -10.72%-10.29M | 42.98%-4.54M | 6.41%-6.43M | -315.57%-2.9M | 75.45%-9.29M | 77.13%-7.96M | 65.12%-6.88M |
| -Interest expense (Financial expense) | -28.35%50.61K | -27.10%35.52K | -26.09%18.6K | -21.93%90.91K | -21.24%70.64K | -20.59%48.72K | -19.97%25.17K | -62.09%116.46K | -64.30%89.69K | -75.58%61.35K |
| -Interest Income (Financial expense) | -10.15%-5.68M | 25.26%-3.25M | 37.60%-1.45M | 11.54%-7.17M | 9.01%-5.15M | -12.84%-4.35M | -41.31%-2.33M | -20.15%-8.11M | -31.99%-5.66M | -22.10%-3.85M |
| Research and development | -17.60%26.7M | -22.88%17.71M | -21.13%8.92M | -0.20%40.62M | 6.09%32.41M | 19.82%22.97M | 22.63%11.31M | -1.61%40.7M | -2.08%30.55M | -5.90%19.17M |
| Credit Impairment Loss | 184.55%674.34K | 202.58%1.13M | -705.48%-1.03M | -232.13%-1.55M | -167.10%-797.52K | -317.04%-1.1M | -115.41%-127.51K | 441.99%1.17M | 51.08%1.19M | 101.34%508.37K |
| Asset Impairment Loss | 102.67%386.59K | 118.38%2.48M | 217.29%322.26K | -9,971.56%-15.82M | -775.28%-14.46M | -726.21%-13.5M | -36.76%-274.76K | 104.31%160.29K | 1.96%2.14M | 14.60%2.16M |
| Other net revenue | 374.71%86.39M | 748.76%46.76M | 712.39%25.5M | -49.57%16.85M | -30.21%18.2M | -142.00%-7.21M | -65.45%3.14M | 577.39%33.42M | 223.62%26.07M | 112.54%17.16M |
| Fair value change income | 387.71%54.38M | 672.04%30.45M | 413.70%16.2M | -263.22%-10.3M | 95.77%11.15M | -627.04%-5.32M | -300.50%-5.17M | 833.09%6.31M | 143.80%5.7M | 115.45%1.01M |
| Invest income | 52.83%27.95M | 7.79%10.71M | 21.90%8.86M | 90.66%39.76M | 29.63%18.29M | -15.30%9.94M | 48.16%7.27M | 1,332.26%20.86M | 44.35%14.11M | 111.30%11.73M |
| Asset deal income | 32.59%-68.67K | ---68.67K | ---- | -136.68%-928.41K | ---101.86K | ---- | ---- | ---392.26K | ---- | ---- |
| Other revenue | -25.49%3.07M | -26.18%2.05M | -20.64%1.14M | 7.07%5.69M | 39.96%4.11M | 58.26%2.78M | 47.36%1.44M | -36.77%5.31M | -65.00%2.94M | -74.65%1.76M |
| Operating profit | 413.62%86.7M | 4,973.86%50.37M | 345.87%27.9M | -84.86%20.22M | -86.61%16.88M | -100.92%-1.03M | -89.61%6.26M | -35.04%133.62M | -15.04%126.04M | 7.60%112.34M |
| Add:Non operating Income | -26.04%3.24K | -46.49%1.85K | -43.96%1.3K | -24.90%35.6K | 122.74%4.38K | 354.90%3.46K | 329.63%2.32K | 4.29%47.4K | 80.29%1.97K | 55.12%760.11 |
| Less:Non operating expense | -75.85%412.54K | -47.09%412.54K | -90.60%26.31K | -60.03%2.05M | -22.68%1.71M | 12.38%779.77K | -37.01%280.06K | 55.51%5.12M | 19.16%2.21M | 5.02%693.87K |
| Total profit | 468.58%86.29M | 2,860.51%49.96M | 366.16%27.87M | -85.83%18.21M | -87.74%15.18M | -101.62%-1.81M | -90.00%5.98M | -36.51%128.54M | -15.48%123.83M | 7.62%111.65M |
| Less:Income tax cost | 867.84%12.89M | 571.28%6.88M | 1,943.26%3.94M | -88.96%1.81M | -92.01%1.33M | -109.54%-1.46M | -97.64%192.68K | -34.95%16.36M | -13.88%16.68M | 11.38%15.3M |
| Net profit | 430.16%73.4M | 12,430.96%43.08M | 313.65%23.94M | -85.38%16.41M | -87.08%13.84M | -100.36%-349.34K | -88.79%5.79M | -36.73%112.18M | -15.72%107.15M | 7.05%96.34M |
| Net profit from continuing operation | 430.16%73.4M | 12,430.96%43.08M | 313.65%23.94M | -85.38%16.41M | -87.08%13.84M | -100.36%-349.34K | -88.79%5.79M | -36.73%112.18M | -15.72%107.15M | 7.05%96.34M |
| Net profit of parent company owners | 430.16%73.4M | 12,430.96%43.08M | 313.65%23.94M | -85.38%16.41M | -87.08%13.84M | -100.36%-349.34K | -88.79%5.79M | -36.73%112.18M | -15.72%107.15M | 7.05%96.34M |
| Earning per share | ||||||||||
| Basic earning per share | 436.36%0.8099 | 12,584.21%0.4744 | 317.75%0.2636 | -85.25%0.18 | -87.08%0.151 | -100.36%-0.0038 | -88.79%0.0631 | -40.78%1.22 | -22.74%1.1689 | -6.34%1.051 |
| Diluted earning per share | 436.36%0.8099 | 12,584.21%0.4744 | 317.75%0.2636 | -85.25%0.18 | -87.08%0.151 | -100.36%-0.0038 | -88.79%0.0631 | -40.78%1.22 | -22.74%1.1689 | -6.34%1.051 |
| Other composite income | ||||||||||
| Total composite income | 430.16%73.4M | 12,430.96%43.08M | 313.65%23.94M | -85.38%16.41M | -87.08%13.84M | -100.36%-349.34K | -88.79%5.79M | -36.73%112.18M | -15.72%107.15M | 7.05%96.34M |
| Total composite income of parent company owners | 430.16%73.4M | 12,430.96%43.08M | 313.65%23.94M | -85.38%16.41M | -87.08%13.84M | -100.36%-349.34K | -88.79%5.79M | -36.73%112.18M | -15.72%107.15M | 7.05%96.34M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"